BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND EIF4A2, DDX2B, 1974, ENSG00000156976, EIF4F, BM-010, EIF4A
238 results:

  • 1. Association of metastatic pattern in breast cancer with tumor and patient-specific factors: a nationwide autopsy study using artificial intelligence.
    Kazemzadeh F; Snoek JAA; Voorham QJ; van Oijen MGH; Hugen N; Nagtegaal ID
    Breast Cancer; 2024 Mar; 31(2):263-271. PubMed ID: 38133738
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Complication Rates and Risk of Recurrence After Percutaneous Radiofrequency Ablation and Microwave Ablation for the Treatment of liver Tumors: a Meta-analysis.
    Alhasan AS; Daqqaq TS; Alhasan MS; Ghunaim HA; Aboualkheir M
    Acad Radiol; 2024 Apr; 31(4):1288-1301. PubMed ID: 38087720
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors.
    Xiong B; Fu B; Wu Y; Gao F; Hou C
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11607-11617. PubMed ID: 37400572
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. eif4a1 Is a Prognostic Marker and Actionable Target in Human Hepatocellular Carcinoma.
    Steinmann SM; Sánchez-Martín A; Tanzer E; Cigliano A; Pes GM; Simile MM; Desaubry L; Marin JJG; Evert M; Calvisi DF
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768380
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms.
    Chan GKL; Maisel S; Hwang YC; Pascual BC; Wolber RRB; Vu P; Patra KC; Bouhaddou M; Kenerson HL; Lim HC; Long D; Yeung RS; Sethupathy P; Swaney DL; Krogan NJ; Turnham RE; Riehle KJ; Scott JD; Bardeesy N; Gordan JD
    Elife; 2023 Jan; 12():. PubMed ID: 36692000
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Malignant Neoplasms of the Gastrointestinal Tract After Blood or Marrow Transplant.
    McDonald A; Dai C; Meng Q; Hageman L; Richman J; Wu J; Francisco L; Ross E; Balas N; Bosworth A; Te HS; Wong FL; Landier W; Salzman D; Bhatia R; Weisdorf DJ; Forman SJ; Armenian SH; Bhatia S
    JAMA Oncol; 2023 Mar; 9(3):376-385. PubMed ID: 36656600
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Overall and complication-free survival in a large cohort of patients with β-thalassemia major followed over 50 years.
    Forni GL; Gianesin B; Musallam KM; Longo F; Rosso R; Lisi R; Gamberini MR; Pinto VM; Graziadei G; Vitucci A; Bonetti F; Musto P; Piga A; Cappellini MD; Borgna-Pignatti C;
    Am J Hematol; 2023 Mar; 98(3):381-387. PubMed ID: 36588408
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Long-term survival trends in solid cancers in the Nordic countries marking timing of improvements.
    Hemminki K; Försti A; Liska V; Kanerva A; Hemminki O; Hemminki A
    Int J Cancer; 2023 May; 152(9):1837-1846. PubMed ID: 36571455
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Gestational age and cancer risk up to young adulthood in Swedish population born 1974 to 2013: A population-based cohort study.
    Persson MSM; Yin W; Döring N; Risnes K; Weiderpass E; Steliarova-Foucher E; Sandin S
    Int J Cancer; 2022 Apr; 150(8):1269-1280. PubMed ID: 34855204
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. cancer risk in patients with immunoglobulin A nephropathy: a Swedish population-based cohort study.
    Rehnberg J; Ludvigsson JF; Carrero JJ; Emilsson L
    Nephrol Dial Transplant; 2022 Mar; 37(4):749-759. PubMed ID: 34788864
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Risk factors, epidemiology and prognosis of cholangiocarcinoma in Finland.
    Barner-Rasmussen N; Pukkala E; Hadkhale K; Färkkilä M
    United European Gastroenterol J; 2021 Dec; 9(10):1128-1135. PubMed ID: 34533900
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Targeting of eIF6-driven translation induces a metabolic rewiring that reduces NAFLD and the consequent evolution to hepatocellular carcinoma.
    Scagliola A; Miluzio A; Ventura G; Oliveto S; Cordiglieri C; Manfrini N; Cirino D; Ricciardi S; Valenti L; Baselli G; D'Ambrosio R; Maggioni M; Brina D; Bresciani A; Biffo S
    Nat Commun; 2021 Aug; 12(1):4878. PubMed ID: 34385447
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient Screening.
    Lalazar G; Requena D; Ramos-Espiritu L; Ng D; Bhola PD; de Jong YP; Wang R; Narayan NJC; Shebl B; Levin S; Michailidis E; Kabbani M; Vercauteren KOA; Hurley AM; Farber BA; Hammond WJ; Saltsman JA; Weinberg EM; Glickman JF; Lyons BA; Ellison J; Schadde E; Hertl M; Leiting JL; Truty MJ; Smoot RL; Tierney F; Kato T; Wendel HG; LaQuaglia MP; Rice CM; Letai A; Coffino P; Torbenson MS; Ortiz MV; Simon SM
    Cancer Discov; 2021 Oct; 11(10):2544-2563. PubMed ID: 34127480
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. eIF4E-eIF4G complex inhibition synergistically enhances the effect of sorafenib in hepatocellular carcinoma.
    Fang C; Xie H; Zhao J; Wang W; Hou H; Zhang B; Zhou D; Geng X
    Anticancer Drugs; 2021 Sep; 32(8):822-828. PubMed ID: 33783376
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Development and validation of a simple-to-use nomogram to predict liver metastasis in patients with pancreatic neuroendocrine neoplasms: a large cohort study.
    Pan M; Yang Y; Teng T; Lu F; Chen Y; Huang H
    BMC Gastroenterol; 2021 Mar; 21(1):101. PubMed ID: 33663420
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. [Spatial clustering analysis and trend of liver cancer death rate in Shandong province, 1970-2013].
    Fu ZT; Wang HT; Lu ZL; Chen XX; Sun JD; Zhang JY; Chu J; Zhang BY; Xue FZ; Guo XL; Xu AQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Nov; 41(11):1865-1870. PubMed ID: 33297652
    [No Abstract]    [Full Text] [Related]  

  • 17. Hepatocellular carcinoma in young morbid obese patients with non-alcoholic fatty liver disease.
    Tobari M; Hashimoto E; Taniai M; Nishino T; Tokushige K
    Clin J Gastroenterol; 2020 Dec; 13(6):1289-1296. PubMed ID: 32880022
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Extended liver surgery for gallbladder cancer revisited: Is there a role for hepatopancreatoduodenectomy?
    Torres OJM; Alikhanov R; Li J; Serrablo A; Chan AC; de Souza M Fernandes E
    Int J Surg; 2020 Oct; 82S():82-86. PubMed ID: 32535266
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Minimally Invasive Versus Open liver Resection for Hepatocellular Carcinoma in the Setting of Portal Vein Hypertension: Results of an International Multi-institutional Analysis.
    Ruzzenente A; Bagante F; Ratti F; Alaimo L; Marques HP; Silva S; Soubrane O; Endo I; Sahara K; Beal EW; Lam V; Poultsides GA; Makris EA; Popescu I; Alexandrescu S; Martel G; Workneh A; Hugh TJ; Guglielmi A; Aldrighetti L; Pawlik TM
    Ann Surg Oncol; 2020 Sep; 27(9):3360-3371. PubMed ID: 32274662
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Infantile hepatic hemangiomas associated with high-output cardiac failure and pulmonary hypertension.
    Zhang XT; Ren WD; Song G; Xiao YJ; Sun FF; Wang N
    BMC Cardiovasc Disord; 2019 Oct; 19(1):216. PubMed ID: 31601179
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 12.